Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > EBIT

Adverum Biotechnlgs EBIT Chart (ADVM)

Adverum Biotechnlgs annual/quarterly EBIT from 2013 to 2020. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Adverum Biotechnlgs EBIT for the quarter ending June 06, 2020 was $-30m a 42.63% decrease of -13m year over year
  • Adverum Biotechnlgs EBIT for the last 12 months ending June 06, 2020 was $-90m a 33.72% decrease of -30m year over year
  • Adverum Biotechnlgs Annual EBIT for 2019 was $-69m a -6.62% increase of 5m from 2018
  • Adverum Biotechnlgs Annual EBIT for 2018 was $-73m a 20.85% decrease of -15m from 2017
  • Adverum Biotechnlgs Annual EBIT for 2017 was $-58m a 15.00% decrease of -9m from 2016
Other Income Statement Metrics:
  • Adverum Biotechnlgs EBITDA for the quarter ending December 12, 2018 was $-21m a 18.17% decrease of -4m year over year
  • Adverum Biotechnlgs Net Income for the quarter ending December 12, 2018 was $-16m a -9.84% increase of 2m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM EBIT Data

06/2020$-30m
03/2020$-24m
12/2019$-20m
09/2019$-17m
06/2019$-16m
03/2019$-16m
12/2018$-17m
09/2018$-18m
06/2018$-20m
03/2018$-18m

Annual ADVM EBIT Data

2019$-69m
2018$-73m
2017$-58m
2016$-49m
2015$-43m
2014$-24m
2013$-3m
2012$-2m